Literature DB >> 8781964

Evaluation of the efficiency of an assay procedure for gangliosides in human serum.

E Negroni1, V Chigorno, G Tettamanti, S Sonnino.   

Abstract

An efficiency assessment of a ganglioside assay procedure was carried out on human serum gangliosides from healthy subjects of different sex and age. The analysis of the gangliosides, extracted with chloroform/methanol and purified by lipid partitioning, ion exchange column chromatographic separation and desalting procedures as described by Senn et al. (1989) Eur J Biochem 181: 657-62, was performed by HPTLC followed by densitometric quantification. The yield of the procedure, expressed as radioactivity recovery, was determined by adding GM3 ganglioside, tritium labelled at the sialic acid acetyl group and at the C3 position of sphingosine, to the lyophilized serum or by associating it with the serum lipoproteins. In spite of the fact that the extraction and purification procedures were performed exactly as described we found the radioactivity recovery to be variable (25-50%) and much lower than that proposed. Much of the radioactivity was found in the organic phase after lipid partitioning, whilst all the ganglioside purification steps led to some further loss. After the introduction of some modifications to the procedure the recovery improved, reaching 67-79%. The analyses on 33 samples of 5 ml showed a human serum ganglioside content of about 10 nmol ml-1 (as corrected for the recovery), and confirmed that GM3 ganglioside is the main component of the total serum ganglioside mixture.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781964     DOI: 10.1007/bf00731466

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  35 in total

1.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

2.  Shed tumor gangliosides and progression of human neuroblastoma.

Authors:  L Valentino; T Moss; E Olson; H J Wang; R Elashoff; S Ladisch
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

3.  Levels of disialogangliosides in sera of melanoma patients monitored by sensitive thin-layer chromatography and immunostaining.

Authors:  B A Sela; D Iliopoulos; D Guerry; D Herlyn; H Koprowski
Journal:  J Natl Cancer Inst       Date:  1989-10-04       Impact factor: 13.506

4.  A new procedure for the extraction, purification and fractionation of brain gangliosides.

Authors:  G Tettamanti; F Bonali; S Marchesini; V Zambotti
Journal:  Biochim Biophys Acta       Date:  1973-01-19

5.  Ganglioside designation.

Authors:  L Svennerholm
Journal:  Adv Exp Med Biol       Date:  1980       Impact factor: 2.622

6.  Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.

Authors:  D M Marcus; N Latov; B P Hsi; B K Gillard
Journal:  J Neuroimmunol       Date:  1989-12       Impact factor: 3.478

7.  Shedding of gangliosides from tumor cells depends on cell density.

Authors:  G I Shaposhnikova; N V Prokazova; G A Buznikov; N D Zvezdina; N A Teplitz; L D Bergelson
Journal:  Eur J Biochem       Date:  1984-05-02

8.  Shedding of GD2 ganglioside in patients with retinoblastoma.

Authors:  J Portoukalian; M J David; P Gain; M Richard
Journal:  Int J Cancer       Date:  1993-04-01       Impact factor: 7.396

9.  Preparation of GM1 ganglioside molecular species having homogeneous fatty acid and long chain base moieties.

Authors:  S Sonnino; G Kirschner; R Ghidoni; D Acquotti; G Tettamanti
Journal:  J Lipid Res       Date:  1985-02       Impact factor: 5.922

10.  A simple and quantitative purification of glycosphingolipids and phospholipids by thin-layer chromatography blotting.

Authors:  T Taki; T Kasama; S Handa; D Ishikawa
Journal:  Anal Biochem       Date:  1994-12       Impact factor: 3.365

View more
  2 in total

1.  Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells.

Authors:  Alessandro Prinetti; Danilo Millimaggi; Sandra D'Ascenzo; Matilda Clarkson; Arianna Bettiga; Vanna Chigorno; Sandro Sonnino; Antonio Pavan; Vincenza Dolo
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

2.  Brain lipid composition in grey-lethal mutant mouse characterized by severe malignant osteopetrosis.

Authors:  Alessandro Prinetti; Federica Rocchetta; Elvira Costantino; Annalisa Frattini; Elena Caldana; Francesca Rucci; Arianna Bettiga; Pietro L Poliani; Vanna Chigorno; Sandro Sonnino
Journal:  Glycoconj J       Date:  2008-09-10       Impact factor: 2.916

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.